SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-169397
Filing Date
2024-06-27
Accepted
2024-06-26 21:25:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d804510d424b3.htm 424B3 198366
2 GRAPHIC g804510g66i48.jpg GRAPHIC 24543
  Complete submission text file 0001193125-24-169397.txt   233233
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280317 | Film No.: 241075078
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)